|Effectiveness and safety of drug-eluting stents in Ontario|
JV Tu, J Bowen, M Chiu, DT Ko, PC Austin, Y He, R Hopkins, JE Tarride, ...
New England Journal of Medicine 357 (14), 1393-1402, 2007
|A review of the cost of cardiovascular disease|
JE Tarride, M Lim, M DesMeules, W Luo, N Burke, D O’Reilly, J Bowen, ...
Canadian Journal of Cardiology 25 (6), e195-e202, 2009
|The economic burden of schizophrenia in Canada in 2004|
R Goeree, F Farahati, N Burke, G Blackhouse, D O’Reilly, J Pyne, ...
Current medical research and opinion 21 (12), 2017-2028, 2005
|The burden of illness of osteoporosis in Canada|
JE Tarride, RB Hopkins, WD Leslie, S Morin, JD Adachi, A Papaioannou, ...
Osteoporosis International 23, 2591-2600, 2012
|Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?|
EM Pullenayegum, JE Tarride, F Xie, R Goeree, HC Gerstein, D O'Reilly
Value in Health 13 (4), 487-494, 2010
|Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction|
N Burke, JP Whelan, L Goeree, RB Hopkins, K Campbell, R Goeree, ...
Urology 75 (5), 1015-1022, 2010
|The current economic burden of illness of osteoporosis in Canada|
RB Hopkins, N Burke, C Von Keyserlingk, WD Leslie, SN Morin, ...
Osteoporosis International 27, 3023-3032, 2016
|Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement|
F Xie, SC Li, R Goeree, JE Tarride, D O’Reilly, NN Lo, SJ Yeo, KY Yang, ...
Quality of Life Research 17, 595-601, 2008
|Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another|
R Goeree, N Burke, D O'Reilly, A Manca, G Blackhouse, JE Tarride
Current medical research and opinion 23 (4), 671-682, 2007
|Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application|
R Goeree, J He, D O’Reilly, JE Tarride, F Xie, M Lim, N Burke
ClinicoEconomics and Outcomes Research, 89-104, 2011
|Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective|
JE Tarride, A Gordon, M Vera-Llonch, E Dukes, C Rousseau
Clinical therapeutics 28 (11), 1922-1934, 2006
|Bariatric surgery and cardiovascular outcomes in patients with obesity and cardiovascular disease: a population-based retrospective cohort study|
AG Doumouras, JA Wong, JM Paterson, Y Lee, B Sivapathasundaram, ...
Circulation 143 (15), 1468-1480, 2021
|A review of health utilities across conditions common in paediatric and adult populations|
JE Tarride, N Burke, M Bischof, RB Hopkins, L Goeree, K Campbell, F Xie, ...
Health and quality of life outcomes 8, 1-11, 2010
|Estimation of the lifetime risk of hip fracture for women and men in Canada|
RB Hopkins, E Pullenayegum, R Goeree, JD Adachi, A Papaioannou, ...
Osteoporosis international 23, 921-927, 2012
|GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making|
JL Brozek, C Canelo-Aybar, EA Akl, JM Bowen, J Bucher, WA Chiu, ...
Journal of clinical epidemiology 129, 138-150, 2021
|A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs|
JJ Doyle, J Casciano, S Arikian, JE Tarride, MA Gonzalez, R Casciano
Value in Health 4 (1), 16-31, 2001
|Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review|
N Assasi, L Schwartz, JE Tarride, K Campbell, R Goeree
Expert review of pharmacoeconomics & outcomes research 14 (2), 203-220, 2014
|Simulating an emergency department: the importance of modeling the interactions between physicians and delegates in a discrete event simulation|
ME Lim, A Worster, R Goeree, JÉ Tarride
BMC medical informatics and decision making 13 (1), 1-11, 2013
|Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada|
DJ O’Reilly, F Xie, E Pullenayegum, HC Gerstein, J Greb, GK Blackhouse, ...
Quality of Life Research 20, 939-943, 2011
|The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis|
KL Lanctôt, ST Masoud, BA Paes, JE Tarride, A Chiu, C Hui, PL Francis, ...
Current medical research and opinion 24 (11), 3223-3237, 2008